Drug class

Anticoagulant Reversal Agent for Dabigatran

An anticoagulant reversal agent for dabigatran is a targeted therapeutic class currently represented by the monoclonal antibody fragment idarucizumab. Read more about Anticoagulant Reversal Agent for Dabigatran

1 drugs in this class 1 manufacturers

Advertisement

Drugs in Anticoagulant Reversal Agent for Dabigatran

Showing 1–1 of 1 drugs

PRAXBIND (idarucizumab)

ANTICOAGULANT REVERSAL AGENT FOR DABIGATRAN · REVERSAL OF DABIGATRAN-INDUCED ANTICOAGULATION
Boehringer Ingelheim
Filter & compare in the drug finder → Opens the drug finder with Anticoagulant Reversal Agent for Dabigatran preselected. Add indication or manufacturer filters there.

About Anticoagulant Reversal Agent for Dabigatran.

An anticoagulant reversal agent for dabigatran is a targeted therapeutic class currently represented by the monoclonal antibody fragment idarucizumab.

It functions by specifically binding free and thrombin-bound dabigatran with high affinity, neutralizing its direct thrombin-inhibiting activity and rapidly restoring normal physiological hemostasis.

Clinically, this class is utilized in emergency medicine and acute critical care for adult patients requiring rapid reversal of dabigatran anticoagulation, specifically during life-threatening or uncontrolled bleeding events and in situations necessitating emergent surgical or invasive procedures.